1 2615 133 YOGA FOR SCHIZOPHRENIA: PATIENTS' PERSPECTIVE. CONTEXT: YOGA-BASED INTERVENTION IS EMERGING AS AN EFFECTIVE ADD-ON THERAPY IN THE MANAGEMENT OF SCHIZOPHRENIA. HOWEVER, MANY BARRIERS MAKE IT DIFFICULT FOR PATIENTS TO AVAIL YOGA THERAPY PROGRAMS. ONE OF THEM IS MOTIVATION FOR YOGA THERAPY. WAYS TO ADDRESS THE BARRIERS ARE CRITICAL TO EMPLOY YOGA AS A TREATMENT IN THIS POPULATION. AIM: THIS STUDY AIMS AT EXPLORING PATIENTS' WILLINGNESS TO PARTICIPATE IN ADD-ON YOGA THERAPY PROGRAMS ON OUT-PATIENT BASIS. SETTINGS AND DESIGN: THE STUDY WAS CONDUCTED ON 100 SCHIZOPHRENIA PATIENTS ATTENDING PSYCHIATRY OUT-PATIENT SERVICES OF A TERTIARY CARE HOSPITAL. MATERIALS AND METHODS: A TOTAL OF 100 SCHIZOPHRENIA PATIENTS (MALE: FEMALE = 57:43; AGE: 35.8 +/- 9.2 YEARS) ATTENDING THE PSYCHIATRY OUT-PATIENT SERVICES OF A TERTIARY NEUROPSYCHIATRY HOSPITAL WERE ADMINISTERED A SURVEY QUESTIONNAIRE. STATISTICAL ANALYSIS USED: CHI-SQUARE TEST WAS USED FOR TESTING THE SIGNIFICANCE OF PROPORTIONS. P < 0.05 WAS TAKEN TO BE SIGNIFICANT. RESULTS: ABOUT 46% WERE AWARE THAT YOGA IS ALSO ONE OF THE COMPLEMENTARY THERAPIES USEFUL IN SCHIZOPHRENIA. 32% HAD TRIED YOGA IN THE PAST FOR SOME REASONS, BUT ONLY 31% OF THEM WERE CONTINUING YOGA; COMMONEST REASONS FOR NOT CONTINUING BEING LACK OF MOTIVATION (31%) AND INABILITY TO SPARE TIME (27.6%). HOWEVER, THE MAJORITY (88.5%) OF THEM WERE WILLING TO TAKE UP ADD-ON YOGA THERAPY ON OUT-PATIENT BASIS ALONG WITH THEIR REGULAR MEDICAL FOLLOW-UP. CONCLUSIONS: IN SPITE OF THE LACK OF MOTIVATION TO PRACTICE YOGA, THE MAJORITY OF PATIENTS WERE WILLING TO PARTICIPATE IN ADD-ON YOGA THERAPY PROGRAMS IF GIVEN ON OUT-PATIENT BASIS ALONG WITH THEIR REGULAR CONVENTIONAL MEDICAL FOLLOW-UP. 2015 2 2732 31 YOGA ON OUR MINDS: A SYSTEMATIC REVIEW OF YOGA FOR NEUROPSYCHIATRIC DISORDERS. BACKGROUND: THE DEMAND FOR CLINICALLY EFFICACIOUS, SAFE, PATIENT ACCEPTABLE, AND COST-EFFECTIVE FORMS OF TREATMENT FOR MENTAL ILLNESS IS GROWING. SEVERAL STUDIES HAVE DEMONSTRATED BENEFIT FROM YOGA IN SPECIFIC PSYCHIATRIC SYMPTOMS AND A GENERAL SENSE OF WELL-BEING. OBJECTIVE: TO SYSTEMATICALLY EXAMINE THE EVIDENCE FOR EFFICACY OF YOGA IN THE TREATMENT OF SELECTED MAJOR PSYCHIATRIC DISORDERS. METHODS: ELECTRONIC SEARCHES OF THE COCHRANE CENTRAL REGISTER OF CONTROLLED TRIALS AND THE STANDARD BIBLIOGRAPHIC DATABASES, MEDLINE, EMBASE, AND PSYCINFO, WERE PERFORMED THROUGH APRIL 2011 AND AN UPDATED IN JUNE 2011 USING THE KEYWORDS YOGA AND PSYCHIATRY OR DEPRESSION OR ANXIETY OR SCHIZOPHRENIA OR COGNITION OR MEMORY OR ATTENTION AND RANDOMIZED CONTROLLED TRIAL (RCT). STUDIES WITH YOGA AS THE INDEPENDENT VARIABLE AND ONE OF THE ABOVE MENTIONED TERMS AS THE DEPENDENT VARIABLE WERE INCLUDED AND EXCLUSION CRITERIA WERE APPLIED. RESULTS: THE SEARCH YIELDED A TOTAL OF 124 TRIALS, OF WHICH 16 MET RIGOROUS CRITERIA FOR THE FINAL REVIEW. GRADE B EVIDENCE SUPPORTING A POTENTIAL ACUTE BENEFIT FOR YOGA EXISTS IN DEPRESSION (FOUR RCTS), AS AN ADJUNCT TO PHARMACOTHERAPY IN SCHIZOPHRENIA (THREE RCTS), IN CHILDREN WITH ADHD (TWO RCTS), AND GRADE C EVIDENCE IN SLEEP COMPLAINTS (THREE RCTS). RCTS IN COGNITIVE DISORDERS AND EATING DISORDERS YIELDED CONFLICTING RESULTS. NO STUDIES LOOKED AT PRIMARY PREVENTION, RELAPSE PREVENTION, OR COMPARATIVE EFFECTIVENESS VERSUS PHARMACOTHERAPY. CONCLUSION: THERE IS EMERGING EVIDENCE FROM RANDOMIZED TRIALS TO SUPPORT POPULAR BELIEFS ABOUT YOGA FOR DEPRESSION, SLEEP DISORDERS, AND AS AN AUGMENTATION THERAPY. LIMITATIONS OF LITERATURE INCLUDE INABILITY TO DO DOUBLE-BLIND STUDIES, MULTIPLICITY OF COMPARISONS WITHIN SMALL STUDIES, AND LACK OF REPLICATION. BIOMARKER AND NEUROIMAGING STUDIES, THOSE COMPARING YOGA WITH STANDARD PHARMACO- AND PSYCHOTHERAPIES, AND STUDIES OF LONG-TERM EFFICACY ARE NEEDED TO FULLY TRANSLATE THE PROMISE OF YOGA FOR ENHANCING MENTAL HEALTH. 2012 3 940 36 EFFECTS OF 6 MONTHS YOGA PROGRAM ON RENAL FUNCTIONS AND QUALITY OF LIFE IN PATIENTS SUFFERING FROM CHRONIC KIDNEY DISEASE. AIM: TO STUDY THE EFFECT OF 6 MONTHS YOGA PROGRAM IN PATIENTS SUFFERING FROM CHRONIC KIDNEY DISEASE (CKD). MATERIALS AND METHODS: FIFTY-FOUR PATIENTS WITH CKD WERE STUDIED AND DIVIDED INTO TWO GROUPS (YOGA GROUP AND CONTROL GROUP) TO SEE THE EFFECT OF YOGA IN CKD. PATIENTS IN THE YOGA GROUP WERE OFFERED YOGA THERAPY ALONG WITH OTHER CONVENTIONAL TREATMENT MODALITIES, WHILE THE CONTROL GROUP WAS ONLY ON CONVENTIONAL TREATMENT. SUBJECTS IN YOGA GROUP WERE TRAINED TO PERFORM SPECIFIC YOGIC ASANAS FOR AT LEAST 5 DAYS A WEEK FOR 40-60 MIN A DAY. REGULAR MONITORING OF BLOOD PRESSURE, RENAL FUNCTION, REQUIREMENT OF A NUMBER OF DIALYSIS, AND QUALITY OF LIFE (QOL) INDICATORS WERE DONE. FIFTY PATIENTS (YOGA - 25; CONTROL-25) COMPLETED 6 MONTHS FOLLOW-UP. RESULTS: IN YOGA GROUP, A SIGNIFICANT REDUCTION OF SYSTOLIC AND DIASTOLIC BLOOD PRESSURE, SIGNIFICANT REDUCTION IN BLOOD UREA AND SERUM CREATININE LEVELS, AND SIGNIFICANT IMPROVEMENT IN PHYSICAL AND PSYCHOLOGICAL DOMAIN OF THE WORLD HEALTH ORGANIZATION QOL (AS ASSESSED BY BREF QOL SCORES) WERE SEEN AFTER 6 MONTHS. IN CONTROL GROUP, RISE OF BLOOD PRESSURE, DETERIORATION OF RENAL FUNCTION, AND QOL WERE OBSERVED. POSTSTUDY COMPARISON BETWEEN THE TWO GROUPS SHOWED A STATISTICALLY SIGNIFICANT REDUCTION OF BLOOD PRESSURE, NONSIGNIFICANT REDUCTION IN BLOOD UREA AND SERUM CREATININE, AND SIGNIFICANT IMPROVEMENT IN PHYSICAL AND PSYCHOLOGICAL DOMAIN OF QOL IN YOGA GROUP AS COMPARED TO CONTROL GROUP. FOR SUBJECTS IN YOGA GROUP, THE NEED FOR DIALYSIS WAS LESS WHEN COMPARED TO CONTROL GROUP ALTHOUGH THIS DIFFERENCE WAS STATISTICALLY INSIGNIFICANT. EXCEPT FOR INABILITY OF SOME PATIENTS TO PERFORM CERTAIN YOGIC ASANAS NO ADVERSE EFFECT WAS FOUND IN THE STUDY. CONCLUSION: SIX MONTHS YOGA PROGRAM IS SAFE AND EFFECTIVE AS AN ADJUVANT THERAPY IN IMPROVING RENAL FUNCTIONS AND QOL OF CKD PATIENTS. 2017 4 2522 27 YOGA DECREASES KYPHOSIS IN SENIOR WOMEN AND MEN WITH ADULT-ONSET HYPERKYPHOSIS: RESULTS OF A RANDOMIZED CONTROLLED TRIAL. OBJECTIVES: TO ASSESS WHETHER A SPECIFICALLY DESIGNED YOGA INTERVENTION CAN REDUCE HYPERKYPHOSIS. DESIGN: A 6-MONTH, TWO-GROUP, RANDOMIZED, CONTROLLED, SINGLE-MASKED TRIAL. SETTING: COMMUNITY RESEARCH UNIT. PARTICIPANTS: ONE HUNDRED EIGHTEEN WOMEN AND MEN AGED 60 AND OLDER WITH A KYPHOSIS ANGLE OF 40 DEGREES OR GREATER. MAJOR EXCLUSIONS WERE SERIOUS MEDICAL COMORBIDITY, USE OF ASSISTIVE DEVICE, INABILITY TO HEAR OR SEE ADEQUATELY FOR PARTICIPATION, AND INABILITY TO PASS A PHYSICAL SAFETY SCREEN. INTERVENTION: THE ACTIVE TREATMENT GROUP ATTENDED HOUR-LONG YOGA CLASSES 3 DAYS PER WEEK FOR 24 WEEKS. THE CONTROL GROUP ATTENDED A MONTHLY LUNCHEON AND SEMINAR AND RECEIVED MAILINGS. MEASUREMENTS: PRIMARY OUTCOMES WERE CHANGE (BASELINE TO 6 MONTHS) IN DEBRUNNER KYPHOMETER-ASSESSED KYPHOSIS ANGLE, STANDING HEIGHT, TIMED CHAIR STANDS, FUNCTIONAL REACH, AND WALKING SPEED. SECONDARY OUTCOMES WERE CHANGE IN KYPHOSIS INDEX, FLEXICURVE KYPHOSIS ANGLE, RANCHO BERNARDO BLOCKS POSTURE ASSESSMENT, AND HEALTH-RELATED QUALITY OF LIFE (HRQOL). RESULTS: COMPARED WITH CONTROL PARTICIPANTS, PARTICIPANTS RANDOMIZED TO YOGA EXPERIENCED A 4.4% IMPROVEMENT IN FLEXICURVE KYPHOSIS ANGLE (P=.006) AND A 5% IMPROVEMENT IN KYPHOSIS INDEX (P=.004). THE INTERVENTION DID NOT RESULT IN STATISTICALLY SIGNIFICANT IMPROVEMENT IN DEBRUNNER KYPHOMETER ANGLE, MEASURED PHYSICAL PERFORMANCE, OR SELF-ASSESSED HRQOL (EACH P>.1). CONCLUSION: THE DECREASE IN FLEXICURVE KYPHOSIS ANGLE IN THE YOGA TREATMENT GROUP SHOWS THAT HYPERKYPHOSIS IS REMEDIABLE, A CRITICAL FIRST STEP IN THE PATHWAY TO TREATING OR PREVENTING THIS CONDITION. LARGER, MORE-DEFINITIVE STUDIES OF YOGA OR OTHER INTERVENTIONS FOR HYPERKYPHOSIS SHOULD BE CONSIDERED. TARGETING INDIVIDUALS WITH MORE-MALLEABLE SPINES AND USING LONGITUDINALLY PRECISE MEASURES OF KYPHOSIS COULD STRENGTHEN THE TREATMENT EFFECT. 2009 5 1822 33 PROTOCOL TO EVALUATE THE IMPACT OF YOGA SUPPLEMENTATION ON COGNITIVE FUNCTION IN SCHIZOPHRENIA: A RANDOMISED CONTROLLED TRIAL. BACKGROUND: SCHIZOPHRENIA (SZ) IS A CHRONIC ILLNESS THAT IS TREATED SYMPTOMATICALLY. COGNITIVE DYSFUNCTION IS A CORE FEATURE OF SZ THAT IS RELATIVELY INTRACTABLE TO PHARMACOTHERAPY. YOGA CAN IMPROVE COGNITIVE FUNCTION AMONG HEALTHY INDIVIDUALS. A RECENT OPEN TRIAL INDICATED SIGNIFICANT BENEFITS OF YOGA TRAINING (YT) IN CONJUNCTION WITH CONVENTIONAL PHARMACOTHERAPY AMONG PATIENTS WITH SZ. AIMS: TO DESCRIBE THE PROTOCOL FOR AN ONGOING RANDOMISED CONTROLLED TRIAL DESIGNED TO TEST WHETHER THE REPORTED BENEFICIAL EFFECTS OF YT ON COGNITIVE FUNCTION AMONG SZ PATIENTS CAN BE REPLICATED. SECONDARILY, THE EFFECTS OF YT ON DAILY FUNCTIONING LIVING SKILLS ARE EVALUATED. METHODS: CONSENTING PATIENTS WITH SZ RECEIVE ROUTINE CLINICAL TREATMENT AND ARE RANDOMISED TO ADJUNCTIVE YT, ADJUNCTIVE PHYSICAL EXERCISE (PE) OR TREATMENT AS USUAL (PROPOSED N = 234 TOTAL, N = 78 IN EACH GROUP). THE TRIAL INVOLVES YT OR PE 5 DAYS A WEEK AND LASTS 3 WEEKS. PARTICIPANTS ARE EVALUATED THRICE OVER 6 MONTHS. COGNITIVE FUNCTIONS MEASURED BY TRAIL MAKING TEST, UNIVERSITY OF PENNSYLVANIA NEUROCOGNITIVE COMPUTERISED BATTERY WERE PRIMARY OUTCOME MEASURES WHILE CLINICAL SEVERITY AND DAILY FUNCTIONING MEASURED BY INDEPENDENT LIVING SKILLS SURVEY WERE SECONDARY OUTCOME MEASURES. RESULTS: A TOTAL OF 309 PARTICIPANTS HAVE BEEN RANDOMISED AS OF 31 AUGUST 2013, WHICH EXCEEDED BEYOND 294 PROPOSED AFTER ATTRITION. ONCE PARTICIPANTS BEGIN YT OR PE THEY GENERALLY COMPLETE THE PROTOCOL. NO INJURIES HAVE BEEN REPORTED. CONCLUSIONS: SHORT TERM YT IS FEASIBLE AND ACCEPTABLE TO INDIAN SZ PATIENTS. IF BENEFICIAL EFFECTS OF YT ARE DETECTED, IT WILL PROVIDE A NOVEL ADJUNCTIVE COGNITIVE REMEDIATION STRATEGY FOR SZ PATIENTS. 2014 6 161 28 A RANDOMISED CONTROLLED TRIAL OF ADJUNCTIVE YOGA AND ADJUNCTIVE PHYSICAL EXERCISE TRAINING FOR COGNITIVE DYSFUNCTION IN SCHIZOPHRENIA. BACKGROUND: YOGA AND PHYSICAL EXERCISE HAVE BEEN USED AS ADJUNCTIVE INTERVENTION FOR COGNITIVE DYSFUNCTION IN SCHIZOPHRENIA (SZ), BUT CONTROLLED COMPARISONS ARE LACKING. AIMS A SINGLE-BLIND RANDOMISED CONTROLLED TRIAL WAS DESIGNED TO EVALUATE WHETHER YOGA TRAINING OR PHYSICAL EXERCISE TRAINING ENHANCE COGNITIVE FUNCTIONS IN SZ, BASED ON A PRIOR PILOT STUDY. METHODS: CONSENTING, CLINICALLY STABLE, ADULT OUTPATIENTS WITH SZ (N=286) COMPLETED BASELINE ASSESSMENTS AND WERE RANDOMISED TO TREATMENT AS USUAL (TAU), SUPERVISED YOGA TRAINING WITH TAU (YT) OR SUPERVISED PHYSICAL EXERCISE TRAINING WITH TAU (PE). BASED ON THE PILOT STUDY, THE PRIMARY OUTCOME MEASURE WAS SPEED INDEX FOR THE COGNITIVE DOMAIN OF 'ATTENTION' IN THE PENN COMPUTERISED NEUROCOGNITIVE BATTERY. USING MIXED MODELS AND CONTRASTS, COGNITIVE FUNCTIONS AT BASELINE, 21 DAYS (END OF TRAINING), 3 AND 6 MONTHS POST-TRAINING WERE EVALUATED WITH INTENTION-TO-TREAT PARADIGM. RESULTS: SPEED INDEX OF ATTENTION DOMAIN IN THE YT GROUP SHOWED GREATER IMPROVEMENT THAN PE AT 6 MONTHS FOLLOW-UP (P<0.036, EFFECT SIZE 0.51). IN THE PE GROUP, 'ACCURACY INDEX OF ATTENTION DOMAIN SHOWED GREATER IMPROVEMENT THAN TAU ALONE AT 6-MONTH FOLLOW-UP (P<0.025, EFFECT SIZE 0.61). FOR SEVERAL OTHER COGNITIVE DOMAINS, SIGNIFICANT IMPROVEMENTS WERE OBSERVED WITH YT OR PE COMPARED WITH TAU ALONE (P<0.05, EFFECT SIZES 0.30-1.97). CONCLUSIONS: BOTH YT AND PE IMPROVED ATTENTION AND ADDITIONAL COGNITIVE DOMAINS WELL PAST THE TRAINING PERIOD, SUPPORTING OUR PRIOR REPORTED BENEFICIAL EFFECT OF YT ON SPEED INDEX OF ATTENTION DOMAIN. AS ADJUNCTS, YT OR PE CAN BENEFIT INDIVIDUALS WITH SZ. 2017 7 289 32 ADJUNCTIVE YOGA TRAINING FOR PERSONS WITH SCHIZOPHRENIA: WHO BENEFITS? OBJECTIVE: THE AIM OF THIS STUDY WAS TO IDENTIFY FACTORS ASSOCIATED WITH ACCEPTABILITY AND EFFICACY OF YOGA TRAINING (YT) FOR IMPROVING COGNITIVE DYSFUNCTION IN INDIVIDUALS WITH SCHIZOPHRENIA (SZ). METHODS: WE ANALYSED DATA FROM TWO PUBLISHED CLINICAL TRIALS OF YT FOR COGNITIVE DYSFUNCTION AMONG INDIANS WITH SZ: (1) A 21-DAY RANDOMISED CONTROLLED TRIAL (RCT, N = 286), 3 AND 6 MONTHS FOLLOW-UP AND (2) A 21-DAY OPEN TRIAL (N = 62). MULTIVARIATE ANALYSES WERE CONDUCTED TO EXAMINE THE ASSOCIATION OF BASELINE CHARACTERISTICS (AGE, SEX, SOCIO-ECONOMIC STATUS, EDUCATIONAL STATUS, DURATION, AND SEVERITY OF ILLNESS) WITH IMPROVEMENT IN COGNITION (I.E. ATTENTION AND FACE MEMORY) FOLLOWING YT. FACTORS ASSOCIATED WITH ACCEPTABILITY WERE IDENTIFIED BY COMPARING BASELINE DEMOGRAPHIC VARIABLES BETWEEN SCREENED AND ENROLLED PARTICIPANTS AS WELL AS COMPLETERS VERSUS NON-COMPLETERS. RESULTS: ENROLLED PARTICIPANTS WERE YOUNGER THAN SCREENED PERSONS WHO DECLINED PARTICIPATION (T = 2.952, P = 0.003). NO OTHER CHARACTERISTICS WERE ASSOCIATED WITH STUDY ENROLLMENT OR COMPLETION. REGARDING EFFICACY, SCHOOLING DURATION WAS NOMINALLY ASSOCIATED WITH GREATER AND SUSTAINED COGNITIVE IMPROVEMENT ON A MEASURE OF FACIAL MEMORY. NO OTHER BASELINE CHARACTERISTICS WERE ASSOCIATED WITH EFFICACY OF YT IN THE OPEN TRIAL, THE RCT, OR THE COMBINED SAMPLES (N = 148). CONCLUSIONS: YT IS ACCEPTABLE EVEN AMONG YOUNGER INDIVIDUALS WITH SZ. IT ALSO ENHANCES SPECIFIC COGNITIVE FUNCTIONS, REGARDLESS OF INDIVIDUAL DIFFERENCES IN SELECTED PSYCHOSOCIAL CHARACTERISTICS. THUS, YOGA COULD BE INCORPORATED AS ADJUNCTIVE THERAPY FOR PATIENTS WITH SZ. IMPORTANTLY, OUR RESULTS SUGGEST COGNITIVE DYSFUNCTION IS REMEDIABLE IN PERSONS WITH SZ ACROSS THE AGE SPECTRUM. 2021 8 2782 30 YOGA THERAPY AS AN ADD-ON TREATMENT IN THE MANAGEMENT OF PATIENTS WITH SCHIZOPHRENIA--A RANDOMIZED CONTROLLED TRIAL. OBJECTIVE: TREATMENT OF SCHIZOPHRENIA HAS REMAINED UNSATISFACTORY DESPITE THE AVAILABILITY OF ANTIPSYCHOTICS. THIS STUDY EXAMINED THE EFFICACY OF YOGA THERAPY (YT) AS AN ADD-ON TREATMENT TO THE ONGOING ANTIPSYCHOTIC TREATMENT. METHOD: SIXTY-ONE MODERATELY ILL SCHIZOPHRENIA PATIENTS WERE RANDOMLY ASSIGNED TO YT (N = 31) AND PHYSICAL EXERCISE THERAPY (PT; N = 30) FOR 4 MONTHS. THEY WERE ASSESSED AT BASELINE AND 4 MONTHS AFTER THE START OF INTERVENTION, BY A RATER WHO WAS BLIND TO THEIR GROUP STATUS. RESULTS: FORTY-ONE SUBJECTS (YT = 21; PT = 20) WERE AVAILABLE AT THE END OF 4 MONTHS FOR ASSESSMENT. SUBJECTS IN THE YT GROUP HAD SIGNIFICANTLY LESS PSYCHOPATHOLOGY THAN THOSE IN THE PT GROUP AT THE END OF 4 MONTHS. THEY ALSO HAD SIGNIFICANTLY GREATER SOCIAL AND OCCUPATIONAL FUNCTIONING AND QUALITY OF LIFE. CONCLUSION: BOTH NON-PHARMACOLOGICAL INTERVENTIONS CONTRIBUTE TO REDUCTION IN SYMPTOMS, WITH YT HAVING BETTER EFFICACY. 2007 9 2543 47 YOGA FOR ASTHMA. BACKGROUND: ASTHMA IS A COMMON CHRONIC INFLAMMATORY DISORDER AFFECTING ABOUT 300 MILLION PEOPLE WORLDWIDE. AS A HOLISTIC THERAPY, YOGA HAS THE POTENTIAL TO RELIEVE BOTH THE PHYSICAL AND PSYCHOLOGICAL SUFFERING OF PEOPLE WITH ASTHMA, AND ITS POPULARITY HAS EXPANDED GLOBALLY. A NUMBER OF CLINICAL TRIALS HAVE BEEN CARRIED OUT TO EVALUATE THE EFFECTS OF YOGA PRACTICE, WITH INCONSISTENT RESULTS. OBJECTIVES: TO ASSESS THE EFFECTS OF YOGA IN PEOPLE WITH ASTHMA. SEARCH METHODS: WE SYSTEMATICALLY SEARCHED THE COCHRANE AIRWAYS GROUP REGISTER OF TRIALS, WHICH IS DERIVED FROM SYSTEMATIC SEARCHES OF BIBLIOGRAPHIC DATABASES INCLUDING THE COCHRANE CENTRAL REGISTER OF CONTROLLED TRIALS (CENTRAL), MEDLINE, EMBASE, CINAHL, AMED, AND PSYCINFO, AND HANDSEARCHING OF RESPIRATORY JOURNALS AND MEETING ABSTRACTS. WE ALSO SEARCHED PEDRO. WE SEARCHED CLINICALTRIALS.GOV AND THE WHO ICTRP SEARCH PORTAL. WE SEARCHED ALL DATABASES FROM THEIR INCEPTION TO 22 JULY 2015, AND USED NO RESTRICTION ON LANGUAGE OF PUBLICATION. WE CHECKED THE REFERENCE LISTS OF ELIGIBLE STUDIES AND RELEVANT REVIEW ARTICLES FOR ADDITIONAL STUDIES. WE ATTEMPTED TO CONTACT INVESTIGATORS OF ELIGIBLE STUDIES AND EXPERTS IN THE FIELD TO LEARN OF OTHER PUBLISHED AND UNPUBLISHED STUDIES. SELECTION CRITERIA: WE INCLUDED RANDOMISED CONTROLLED TRIALS (RCTS) THAT COMPARED YOGA WITH USUAL CARE (OR NO INTERVENTION) OR SHAM INTERVENTION IN PEOPLE WITH ASTHMA AND REPORTED AT LEAST ONE OF THE FOLLOWING OUTCOMES: QUALITY OF LIFE, ASTHMA SYMPTOM SCORE, ASTHMA CONTROL, LUNG FUNCTION MEASURES, ASTHMA MEDICATION USAGE, AND ADVERSE EVENTS. DATA COLLECTION AND ANALYSIS: WE EXTRACTED BIBLIOGRAPHIC INFORMATION, CHARACTERISTICS OF PARTICIPANTS, CHARACTERISTICS OF INTERVENTIONS AND CONTROLS, CHARACTERISTICS OF METHODOLOGY, AND RESULTS FOR THE OUTCOMES OF OUR INTEREST FROM ELIGIBLE STUDIES. FOR CONTINUOUS OUTCOMES, WE USED MEAN DIFFERENCE (MD) WITH 95% CONFIDENCE INTERVAL (CI) TO DENOTE THE TREATMENT EFFECTS, IF THE OUTCOMES WERE MEASURED BY THE SAME SCALE ACROSS STUDIES. ALTERNATIVELY, IF THE OUTCOMES WERE MEASURED BY DIFFERENT SCALES ACROSS STUDIES, WE USED STANDARDISED MEAN DIFFERENCE (SMD) WITH 95% CI. FOR DICHOTOMOUS OUTCOMES, WE USED RISK RATIO (RR) WITH 95% CI TO MEASURE THE TREATMENT EFFECTS. WE PERFORMED META-ANALYSIS WITH REVIEW MANAGER 5.3. WE USED THE FIXED-EFFECT MODEL TO POOL THE DATA, UNLESS THERE WAS SUBSTANTIAL HETEROGENEITY AMONG STUDIES, IN WHICH CASE WE USED THE RANDOM-EFFECTS MODEL INSTEAD. FOR OUTCOMES INAPPROPRIATE OR IMPOSSIBLE TO POOL QUANTITATIVELY, WE CONDUCTED A DESCRIPTIVE ANALYSIS AND SUMMARISED THE FINDINGS NARRATIVELY. MAIN RESULTS: WE INCLUDED 15 RCTS WITH A TOTAL OF 1048 PARTICIPANTS. MOST OF THE TRIALS WERE CONDUCTED IN INDIA, FOLLOWED BY EUROPE AND THE UNITED STATES. THE MAJORITY OF PARTICIPANTS WERE ADULTS OF BOTH SEXES WITH MILD TO MODERATE ASTHMA FOR SIX MONTHS TO MORE THAN 23 YEARS. FIVE STUDIES INCLUDED YOGA BREATHING ALONE, WHILE THE OTHER STUDIES ASSESSED YOGA INTERVENTIONS THAT INCLUDED BREATHING, POSTURE, AND MEDITATION. INTERVENTIONS LASTED FROM TWO WEEKS TO 54 MONTHS, FOR NO MORE THAN SIX MONTHS IN THE MAJORITY OF STUDIES. THE RISK OF BIAS WAS LOW ACROSS ALL DOMAINS IN ONE STUDY AND UNCLEAR OR HIGH IN AT LEAST ONE DOMAIN FOR THE REMAINDER.THERE WAS SOME EVIDENCE THAT YOGA MAY IMPROVE QUALITY OF LIFE (MD IN ASTHMA QUALITY OF LIFE QUESTIONNAIRE (AQLQ) SCORE PER ITEM 0.57 UNITS ON A 7-POINT SCALE, 95% CI 0.37 TO 0.77; 5 STUDIES; 375 PARTICIPANTS), IMPROVE SYMPTOMS (SMD 0.37, 95% CI 0.09 TO 0.65; 3 STUDIES; 243 PARTICIPANTS), AND REDUCE MEDICATION USAGE (RR 5.35, 95% CI 1.29 TO 22.11; 2 STUDIES) IN PEOPLE WITH ASTHMA. THE MD FOR AQLQ SCORE EXCEEDED THE MINIMAL CLINICALLY IMPORTANT DIFFERENCE (MCID) OF 0.5, BUT WHETHER THE MEAN CHANGES EXCEEDED THE MCID FOR ASTHMA SYMPTOMS IS UNCERTAIN DUE TO THE LACK OF AN ESTABLISHED MCID IN THE SEVERITY SCORES USED IN THE INCLUDED STUDIES. THE EFFECTS OF YOGA ON CHANGE FROM BASELINE FORCED EXPIRATORY VOLUME IN ONE SECOND (MD 0.04 LITRES, 95% CI -0.10 TO 0.19; 7 STUDIES; 340 PARTICIPANTS; I(2) = 68%) WERE NOT STATISTICALLY SIGNIFICANT. TWO STUDIES INDICATED IMPROVED ASTHMA CONTROL, BUT DUE TO VERY SIGNIFICANT HETEROGENEITY (I(2) = 98%) WE DID NOT POOL DATA. NO SERIOUS ADVERSE EVENTS ASSOCIATED WITH YOGA WERE REPORTED, BUT THE DATA ON THIS OUTCOME WAS LIMITED. AUTHORS' CONCLUSIONS: WE FOUND MODERATE-QUALITY EVIDENCE THAT YOGA PROBABLY LEADS TO SMALL IMPROVEMENTS IN QUALITY OF LIFE AND SYMPTOMS IN PEOPLE WITH ASTHMA. THERE IS MORE UNCERTAINTY ABOUT POTENTIAL ADVERSE EFFECTS OF YOGA AND ITS IMPACT ON LUNG FUNCTION AND MEDICATION USAGE. RCTS WITH A LARGE SAMPLE SIZE AND HIGH METHODOLOGICAL AND REPORTING QUALITY ARE NEEDED TO CONFIRM THE EFFECTS OF YOGA FOR ASTHMA. 2016 10 1912 33 ROLE OF BREATHING EXERCISES AND YOGA/PRANAYAMA IN CHILDHOOD ASTHMA: A SYSTEMATIC REVIEW. BACKGROUND: VARIOUS COMPLEMENTARY OR ALTERNATIVE MEDICINES (INCLUDING BREATHING EXERCISES AND YOGA/PRANAYAMA) HAVE BEEN TRIED AS AN ATTRACTIVE OPTION TO PHARMACOTHERAPY IN CHILDHOOD ASTHMA. OBJECTIVE: TO EVALUATE THE ROLE OF BREATHING EXERCISE AND YOGA/PRANAYAMA AS ADD ON THERAPY TO THE "PHARMACOLOGICALLY RECOMMENDED TREATMENT" OF CHILDHOOD ASTHMA. METHODS: WE SEARCHED THE PUBLISHED LITERATURE IN THE MAJOR DATABASES: MEDLINE VIA OVID, PUBMED, CENTRAL, EMBASE, AND GOOGLE SCHOLAR TILL JUNE 2018. RANDOMIZED TRIALS COMPARING BREATHING EXERCISES AND YOGA/ PRANAYAMA VERSUS CONTROL OR AS PART OF A COMPOSITE INTERVENTION VERSUS CONTROL WERE INCLUDED. THE PRIMARY OUTCOME MEASURES WERE QUALITY OF LIFE AND CHANGE IN ASTHMA SYMPTOMS. SECONDARY OUTCOMES WERE: DECREASE IN MEDICATION USE, NUMBER OF EXACERBATIONS, CHANGE IN LUNG FUNCTION AND IMMUNOLOGICAL PARAMETERS, SCHOOL ABSENTEEISM AND ADVERSE EVENTS. RESULTS: A TOTAL OF 10 TRIALS (466 CHILDREN, 6-14 YEARS AGE) WERE INCLUDED. THE SEVERITY OF ASTHMA VARIED AMONG THE TRIALS. THE DATA FOR PRIMARY OUTCOME MEASURES COULD NOT BE POOLED, THERE WERE MIXED RESULTS FOR BOTH PRIMARY AND SECONDARY OUTCOMES. NO SIGNIFICANT BENEFIT WAS OBTAINED IN ACUTE ASTHMA AND THE LUNG FUNCTION TESTS [EXCEPT PEFR % AT 4-6 WEEKS, PEF ABSOLUTE AT 3 MONTHS, AND FVC ABSOLUTE AT 3 MONTHS] IN CHRONIC ASTHMA. ONE TRIAL COMPARED BREATHING EXERCISE VERSUS YOGA AND FOUND NO DIFFERENCE. ADVERSE EVENTS WERE NOT SIGNIFICANT. CONCLUSIONS: BREATHING EXERCISE AND YOGA/ PRANAYAMA MAY HAVE SOME ADDITIVE ROLE IN THE TREATMENT OF CHILDHOOD ASTHMA. HOWEVER, AT PRESENT, IT CANNOT BE RECOMMENDED AS A STANDARD OF CARE DUE TO INSUFFICIENT DATA. 2019 11 2293 48 THERAPEUTIC EFFICACY OF ADD-ON YOGASANA INTERVENTION IN STABILIZED OUTPATIENT SCHIZOPHRENIA: RANDOMIZED CONTROLLED COMPARISON WITH EXERCISE AND WAITLIST. BACKGROUND: SCHIZOPHRENIA IS A HIGHLY DISABLING ILLNESS. PREVIOUS STUDIES HAVE SHOWN YOGA TO BE A FEASIBLE ADD-ON THERAPY IN SCHIZOPHRENIA. AIMS: THE CURRENT STUDY AIMED TO TEST THE EFFICACY OF YOGA AS AN ADD-ON TREATMENT IN OUTPATIENTS WITH SCHIZOPHRENIA. SETTINGS AND DESIGN: THE STUDY DONE AT A TERTIARY PSYCHIATRY CENTER USED A SINGLE BLIND RANDOMIZED CONTROLLED DESIGN WITH ACTIVE CONTROL AND WAITLIST GROUPS. MATERIALS AND METHODS: CONSENTING PATIENTS WITH SCHIZOPHRENIA WERE RANDOMIZED INTO YOGA, EXERCISE, OR WAITLIST GROUP. THEY CONTINUED TO RECEIVE PHARMACOLOGICAL THERAPY THAT WAS UNCHANGED DURING THE STUDY. PATIENTS IN THE YOGA OR EXERCISE GROUP WERE OFFERED SUPERVISED DAILY PROCEDURES FOR ONE MONTH. ALL PATIENTS WERE ASSESSED BY A BLIND RATER AT THE START OF THE INTERVENTION AND AT THE END OF 4 MONTHS. RESULTS: KENDALL TAU, A NONPARAMETRIC STATISTICAL TEST, SHOWED THAT SIGNIFICANTLY MORE PATIENTS IN THE YOGA GROUP IMPROVED IN POSITIVE AND NEGATIVE SYNDROME SCALE (PANSS) NEGATIVE AND TOTAL PANSS SCORES AS WELL AS SOCIAL FUNCTIONING SCORES COMPARED WITH THE EXERCISE AND WAITLIST GROUP. ODDS RATIO ANALYSIS SHOWED THAT THE LIKELIHOOD OF IMPROVEMENT IN YOGA GROUP IN TERMS OF NEGATIVE SYMPTOMS WAS ABOUT FIVE TIMES GREATER THAN EITHER THE EXERCISE OR WAITLIST GROUPS. CONCLUSION: IN SCHIZOPHRENIA PATIENTS WITH SEVERAL YEARS OF ILLNESS AND ON STABILIZED PHARMACOLOGICAL THERAPY, ONE-MONTH TRAINING FOLLOWED BY THREE MONTHS OF HOME PRACTICES OF YOGA AS AN ADD-ON TREATMENT OFFERED SIGNIFICANT ADVANTAGE OVER EXERCISE OR TREATMENT AS USUAL. YOGA HOLDS PROMISE AS A COMPLEMENTARY INTERVENTION IN THE MANAGEMENT OF SCHIZOPHRENIA. 2012 12 318 34 AN INTEGRATIVE REVIEW OF YOGA AND MINDFULNESS-BASED APPROACHES FOR CHILDREN AND ADOLESCENTS WITH ASTHMA. PROBLEM: ASTHMA AFFECTS ALMOST 15% OF CHILDREN IN THE UNITED STATES. DESPITE THE AVAILABILITY OF TREATMENTS AND EDUCATIONAL METHODS, CHILDREN WITH ASTHMA CONTINUE TO REPORT AN IMPAIRED QUALITY OF LIFE, INCLUDING SYMPTOMS OF ANXIETY AND INABILITY TO PARTICIPATE IN PHYSICAL ACTIVITY. AS COMPLEMENTARY HEALTH APPROACHES ARE BECOMING MORE POPULAR AND SHOW PROMISE IN THE MANAGEMENT OF MANY CHRONIC DISEASES, THE PURPOSE OF THIS INTEGRATIVE REVIEW IS TO EXAMINE THE STATE OF THE SCIENCE REGARDING POPULAR COMPLEMENTARY HEALTH APPROACHES- YOGA AND MINDFULNESS- FOR CHILDREN AND ADOLESCENTS WITH ASTHMA. ELIGIBILITY CRITERIA: A COMPREHENSIVE SEARCH OF FIVE DATABASES FOR PEER REVIEWED ARTICLES WAS PERFORMED TO IDENTIFY EXPERIMENTAL AND NON-EXPERIMENTAL STUDIES. THE SEARCH FOR EACH DATABASE WAS PERFORMED FROM THE INCEPTION OF EACH TO JANUARY 2020 AND LIMITED TO THE ENGLISH LANGUAGE. THE SEARCH INCLUDED TERMINOLOGY THAT ADDRESSED THE CONCEPTS OF "ASTHMA", "YOGA" AND "MINDFULNESS". SAMPLE: A TOTAL OF ELEVEN ARTICLES MET THE CRITERIA FOR REVIEW FROM THE YEARS 1991 TO 2019. RESULTS: NINE PUBLICATIONS FOCUSED ON THE USE OF YOGA IN CHILDREN AND ADOLESCENTS WITH ASTHMA AND TWO PUBLICATIONS FOCUSED ON MINDFULNESS IN ADOLESCENTS WITH ASTHMA. CONCLUSIONS: INTERVENTIONS INVOLVING EITHER MINDFULNESS OR YOGA MAY BE EFFECTIVE IN REDUCING STRESS AND ANXIETY AND IMPROVING QUALITY OF LIFE AND LUNG FUNCTION IN THIS POPULATION. IMPLICATIONS: MINDFULNESS INTERVENTION STUDIES IN THE PEDIATRIC AND ADOLESCENT ASTHMA POPULATION ARE WARRANTED AS ARE ADDITIONAL STUDIES THAT INCLUDE THE USE OF YOGA WITH SKILLS IN MINDFULNESS IN ORDER TO EVALUATE THEIR PHYSIOLOGICAL AND PSYCHOLOGICAL EFFECTS. 2020 13 2664 43 YOGA IN CHILDREN WITH EPILEPSY: A RANDOMIZED CONTROLLED TRIAL. CONTEXT: MAJORITY OF EPILEPSY BEGINS IN CHILDHOOD. TWENTY TO THIRTY PERCENT OF PATIENTS MAY NOT RESPOND TO ANTIEPILEPTIC DRUGS. YOGA AS A COMPLEMENTARY THERAPY HAS BEEN FOUND TO BE BENEFICIAL IN ADULTS, BUT HAS NOT YET BEEN STUDIED IN CHILDREN WITH EPILEPSY. AIM: TO STUDY THE EFFECT OF YOGA ON SEIZURE AND ELECTROENCEPHALOGRAM (EEG) OUTCOME IN CHILDREN WITH EPILEPSY. SETTING AND DESIGN: A RANDOMIZED CONTROLLED TRIAL WAS CONDUCTED IN THE PEDIATRIC NEUROLOGY OUTPATIENT DEPARTMENT OF A TERTIARY CARE TEACHING HOSPITAL. MATERIALS AND METHODS: TWENTY CHILDREN AGED 8-12 YEARS WITH AN UNEQUIVOCAL DIAGNOSIS OF EPILEPSY ON REGULAR ANTIEPILEPTIC DRUGS WERE ENROLLED. YOGA THERAPY WAS PROVIDED TO 10 CHILDREN (STUDY GROUP) AND 10 CHILDREN FORMED THE CONTROL GROUP. YOGA THERAPY WAS GIVEN AS 10 SESSIONS OF 1H EACH. WE COMPARED SEIZURE FREQUENCY AND EEG AT BASELINE, 3, AND 6 MONTHS. STATISTICAL ANALYSIS WAS CARRIED OUT USING STANDARD STATISTICAL TESTS. A P VALUE OF <0.05 WAS CONSIDERED SIGNIFICANT. RESULTS: NO CHILDREN HAD SEIZURES AT THE END OF 3 AND 6 MONTHS IN THE STUDY GROUP. IN THE CONTROL GROUP, AT 3 AND 6 MONTHS, FOUR AND THREE CHILDREN, RESPECTIVELY, HAD SEIZURES. EIGHT CHILDREN EACH IN BOTH THE GROUPS HAD AN ABNORMAL EEG AT ENROLLMENT. AT THE END OF 6 MONTHS, ONE EEG IN THE STUDY GROUP AND SEVEN IN THE CONTROL GROUP WERE ABNORMAL (P = 0.020). CONCLUSION: YOGA AS AN ADDITIONAL THERAPY IN CHILDREN WITH EPILEPSY LEADS TO SEIZURE FREEDOM AND SIGNIFICANT IMPROVEMENT IN EEG AT 6 MONTHS. 2018 14 232 29 A SYSTEMATIC REVIEW OF YOGA FOR MAJOR DEPRESSIVE DISORDER. BACKGROUND: THE PURPOSE OF THIS REVIEW WAS TO INVESTIGATE THE EFFICACY AND SAFETY OF YOGA INTERVENTIONS IN TREATING PATIENTS WITH MAJOR DEPRESSIVE DISORDER. METHODS: MEDLINE, SCOPUS, AND THE COCHRANE LIBRARY WERE SCREENED THROUGH DECEMBER 2016. RANDOMIZED CONTROLLED TRIALS (RCTS) COMPARING YOGA TO INACTIVE OR ACTIVE COMPARATORS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER WERE ELIGIBLE. PRIMARY OUTCOMES INCLUDED REMISSION RATES AND SEVERITY OF DEPRESSION. ANXIETY AND ADVERSE EVENTS WERE SECONDARY OUTCOMES. RISK OF BIAS WAS ASSESSED USING THE COCHRANE TOOL. RESULTS: SEVEN RCTS WITH 240 PARTICIPANTS WERE INCLUDED. RISK OF BIAS WAS UNCLEAR FOR MOST RCTS. COMPARED TO AEROBIC EXERCISE, NO SHORT- OR MEDIUM-TERM GROUP DIFFERENCES IN DEPRESSION SEVERITY WAS FOUND. HIGHER SHORT-TERM DEPRESSION SEVERITY WAS FOUND FOR YOGA COMPARED TO ELECTRO-CONVULSIVE THERAPY; REMISSION RATES DID NOT DIFFER BETWEEN GROUPS. NO SHORT-TERM GROUP DIFFERENCES OCCURRED WHEN YOGA WAS COMPARED TO ANTIDEPRESSANT MEDICATION. CONFLICTING EVIDENCE WAS FOUND WHEN YOGA WAS COMPARED TO ATTENTION-CONTROL INTERVENTIONS, OR WHEN YOGA AS AN ADD-ON TO ANTIDEPRESSANT MEDICATION WAS COMPARED TO MEDICATION ALONE. ONLY TWO RCTS ASSESSED ADVERSE EVENTS AND REPORTED THAT NO TREATMENT-RELATED ADVERSE EVENTS WERE REPORTED. LIMITATIONS: FEW RCTS WITH LOW SAMPLE SIZE. CONCLUSIONS: THIS REVIEW FOUND SOME EVIDENCE FOR POSITIVE EFFECTS BEYOND PLACEBO AND COMPARABLE EFFECTS COMPARED TO EVIDENCE-BASED INTERVENTIONS. HOWEVER, METHODOLOGICAL PROBLEMS AND THE UNCLEAR RISK-BENEFIT RATIO PRECLUDE DEFINITIVE RECOMMENDATIONS FOR OR AGAINST YOGA AS AN ADJUNCT TREATMENT FOR MAJOR DEPRESSIVE DISORDER. LARGER AND ADEQUATELY POWERED RCTS USING NON-INFERIORITY DESIGNS ARE NEEDED. 2017 15 2628 32 YOGA FOR THE MANAGEMENT OF PAIN AND SLEEP IN RHEUMATOID ARTHRITIS: A PILOT RANDOMIZED CONTROLLED TRIAL. OBJECTIVE: THE AIM OF THE PRESENT STUDY WAS TO DETERMINE THE FEASIBILITY OF A RELAXATION-BASED YOGA INTERVENTION FOR RHEUMATOID ARTHRITIS, DESIGNED AND REPORTED IN ACCORDANCE WITH DELPHI RECOMMENDATIONS FOR YOGA INTERVENTIONS FOR MUSCULOSKELETAL CONDITIONS. METHODS: PARTICIPANTS WERE RECRUITED FROM A HOSPITAL DATABASE, AND RANDOMIZED TO EITHER EIGHT WEEKLY 75-MIN YOGA CLASSES OR A USUAL CARE CONTROL. FEASIBILITY WAS DETERMINED BY RECRUITMENT RATES, RETENTION, PROTOCOL ADHERENCE, PARTICIPANT SATISFACTION AND ADVERSE EVENTS. SECONDARY PHYSICAL AND PSYCHOSOCIAL OUTCOMES WERE ASSESSED USING SELF-REPORTED QUESTIONNAIRES AT BASELINE (WEEK 0), WEEK 9 (PRIMARY TIME POINT) AND WEEK 12 (FOLLOW-UP). RESULTS: OVER A 3-MONTH PERIOD, 26 PARTICIPANTS WITH MILD PAIN, MILD TO MODERATE FUNCTIONAL DISABILITY AND MODERATE DISEASE ACTIVITY WERE RECRUITED INTO THE STUDY (25% RECRUITMENT RATE). RETENTION RATES WERE 100% FOR YOGA PARTICIPANTS AND 92% FOR USUAL CARE PARTICIPANTS AT BOTH WEEKS 9 AND 12. PROTOCOL ADHERENCE AND PARTICIPANT SATISFACTION WERE HIGH. YOGA PARTICIPANTS ATTENDED A MEDIAN OF SEVEN CLASSES; ADDITIONALLY, SEVEN OF THE YOGA PARTICIPANTS (54%) REPORTED CONTINUING YOGA AT HOME DURING THE FOLLOW-UP PERIOD. NO SERIOUS ADVERSE EVENTS WERE RELATED TO THE STUDY. SECONDARY OUTCOMES SHOWED NO GROUP EFFECTS OF YOGA COMPARED WITH USUAL CARE. CONCLUSIONS: A RELAXATION-BASED YOGA PROGRAMME WAS FOUND TO BE FEASIBLE AND SAFE FOR PARTICIPANTS WITH RHEUMATOID ARTHRITIS-RELATED PAIN AND FUNCTIONAL DISABILITY. ADVERSE EVENTS WERE MINOR, AND NOT UNEXPECTED FROM AN INTERVENTION INCLUDING PHYSICAL COMPONENTS. THIS PILOT PROVIDES A FRAMEWORK FOR LARGER INTERVENTION STUDIES, AND SUPPORTS FURTHER EXPLORATION OF YOGA AS A COMPLEX INTERVENTION TO ASSIST WITH THE MANAGEMENT OF RHEUMATOID ARTHRITIS. 2018 16 2677 34 YOGA IN SCHIZOPHRENIA: A SYSTEMATIC REVIEW OF RANDOMISED CONTROLLED TRIALS. OBJECTIVE: THE OBJECTIVE OF THIS SYSTEMATIC REVIEW WAS TO ASSESS THE EFFECTIVENESS OF YOGA AS A COMPLEMENTARY TREATMENT ON GENERAL PSYCHOPATHOLOGY, POSITIVE AND NEGATIVE SYMPTOMS AND HEALTH-RELATED QUALITY OF LIFE (HRQL) FOR PEOPLE WITH SCHIZOPHRENIA. METHOD: RANDOMISED CONTROLLED TRIALS (RCTS) WERE CONSIDERED WHETHER THEY INVESTIGATED A YOGA INTERVENTION IN PATIENTS WITH SCHIZOPHRENIA. THE SELECTION OF STUDIES, DATA EXTRACTION AND QUALITY ASSESSMENT WERE PERFORMED INDEPENDENTLY BY TWO REVIEWERS. RESULTS: ONLY THREE RCTS MET THE INCLUSION CRITERIA. LOWER POSITIVE AND NEGATIVE SYNDROME SCALE (PANSS) TOTAL SCORES AND SUBSCALE SCORES FOR POSITIVE AND NEGATIVE SYMPTOMS WERE OBTAINED AFTER YOGA COMPARED WITH EXERCISE OR WAITING LIST CONTROL CONDITIONS. IN THE SAME WAY, THE PHYSICAL, PSYCHOLOGICAL, SOCIAL AND ENVIRONMENTAL HRQL AS MEASURED WITH THE ABBREVIATED VERSION OF THE WORLD HEALTH ORGANIZATION QUALITY OF LIFE QUESTIONNAIRE (WHOQOL-BREF) INCREASED MORE SIGNIFICANTLY AFTER YOGA THAN AFTER EXERCISE OR WAITING LIST CONTROL CONDITIONS. NONE OF THE RCTS ENCOUNTERED ADVERSE EVENTS. DOSE-RESPONSE RELATIONSHIPS COULD, HOWEVER, NOT BE DETERMINED. CONCLUSION: ALTHOUGH THE NUMBER OF RCTS INCLUDED IN THIS REVIEW WAS LIMITED, RESULTS INDICATED THAT YOGA THERAPY CAN BE AN USEFUL ADD-ON TREATMENT TO REDUCE GENERAL PSYCHOPATHOLOGY AND POSITIVE AND NEGATIVE SYMPTOMS. IN THE SAME WAY, HRQL IMPROVED IN THOSE ANTIPSYCHOTIC-STABILISED PATIENTS WITH SCHIZOPHRENIA FOLLOWING YOGA. 2012 17 2496 30 YOGA AS PART OF A PACKAGE OF CARE VERSUS NON-STANDARD CARE FOR SCHIZOPHRENIA. BACKGROUND: YOGA IS AN ANCIENT BODY-MIND PRACTICE WHICH ORIGINATED IN INDIA AND IS POPULAR IN THE WESTERN WORLD AS A FORM OF RELAXATION AND EXERCISE. IT HAS BEEN OF INTEREST FOR PEOPLE WITH SCHIZOPHRENIA TO DETERMINE THE EFFICACY OF YOGA DELIVERED AS A PACKAGE OF CARE VERSUS NON-STANDARD CARE. OBJECTIVES: TO EXAMINE THE EFFECTS OF YOGA AS PART OF A PACKAGE OF CARE VERSUS NON-STANDARD CARE FOR SCHIZOPHRENIA. SEARCH METHODS: WE SEARCHED THE COCHRANE SCHIZOPHRENIA GROUP TRIALS REGISTER (LATEST 15 MAY 2018) WHICH IS BASED ON REGULAR SEARCHES OF MEDLINE, PUBMED, EMBASE, CINAHL, BIOSS, AMED, PSYCHINFO, AND REGISTRIES OF CLINICAL TRIALS. WE SEARCHED THE REFERENCES OF ALL INCLUDED STUDIES. THERE ARE NO LANGUAGE, DATE, DOCUMENT TYPE, OR PUBLICATION STATUS LIMITATIONS FOR INCLUSION OF RECORDS IN THE REGISTER. SELECTION CRITERIA: ALL RANDOMISED CONTROLLED TRIALS (RCTS) INCLUDING PEOPLE WITH SCHIZOPHRENIA COMPARING YOGA AS PART OF A PACKAGE OF CARE WITH NON-STANDARD CARE. DATA COLLECTION AND ANALYSIS: THERE WERE NO DATA TO ANALYSE AS NO STUDIES MET THE INCLUSION CRITERIA. MAIN RESULTS: THE SEARCHES IDENTIFIED 30 STUDIES THAT COULD BE RELEVANT TO THIS REVIEW. AFTER CAREFUL INSPECTION, 29 WERE EXCLUDED AND ONE IS AWAITING CLASSIFICATION. NO DATA WERE AVAILABLE FOR ANALYSES. AUTHORS' CONCLUSIONS: IN VIEW OF THE LACK OF EVIDENCE FROM RCTS, IT IS CURRENTLY NOT POSSIBLE FOR US TO COMMENT ON THE USE OF YOGA AS PART OF A PACKAGE OF CARE VERSUS NON-STANDARD CARE. 2019 18 2858 26 YOGA-BASED CARDIAC REHABILITATION: CURRENT PERSPECTIVES FROM RANDOMIZED CONTROLLED TRIALS IN CORONARY ARTERY DISEASE. CORONARY ARTERY DISEASE CARRIES A HIGH MORBIDITY AND MORTALITY WORLDWIDE, AND EXERCISE-BASED CARDIAC REHABILITATION PROGRAMMES PLAY A LARGE ROLE IN SECONDARY PREVENTION. EXERCISE-BASED REHABILITATION PROGRAMMES ARE EXPENSIVE, AND IN CERTAIN SUBGROUPS UPTAKE IS POOR. YOGA HAS BEEN SUGGESTED TO SHOW IMPROVEMENTS IN CARDIOVASCULAR HEALTH WHICH WOULD SUPPORT ITS USE IN CARDIAC REHABILITATION PROGRAMMES. WE CARRIED OUT A REVIEW OF CURRENT RANDOMIZED CONTROLLED TRIALS TO DETERMINE IF YOGA-BASED CARDIAC REHABILITATION LEADS TO REDUCED CARDIAC RISK FACTORS, AND IMPROVED PHYSIOLOGICAL AND PSYCHOLOGICAL OUTCOMES IN PATIENTS WITH CORONARY ARTERY DISEASE COMPARED TO STANDARD CARE. SIX RANDOMIZED CONTROLLED STUDIES WERE IDENTIFIED AFTER A MEDICAL DATABASE SEARCH, AND META-ANALYSIS WAS CARRIED OUT FOR THE DIFFERENT OUTCOMES. OVERALL, THE ADDITION OF YOGA TO STANDARD CARE RESULTED IN IMPROVED SUBJECTIVE FEELING OF CARDIAC HEALTH AND QUALITY OF LIFE. THERE WAS ALSO A TREND TOWARDS IMPROVEMENT IN LEFT VENTRICULAR SYSTOLIC FUNCTION. IMPROVEMENT IN CARDIAC RISK FACTORS, MACE AND PSYCHOLOGICAL HEALTH IN THIS COHORT HAS STILL TO BE PROVEN, BUT WAS NOT INFERIOR TO STANDARD OR ENHANCED CARE, AND THE BENEFITS BECAME MORE PRONOUNCED AT LONGER FOLLOW-UP. FUTURE STUDIES WITH LONGER FOLLOW-UP AND LARGER PATIENT NUMBERS WOULD AID IN ACCURATELY ASSESSING THE LONG-TERM BENEFIT OF YOGA-BASED REHABILITATION. 2021 19 973 36 EFFECTS OF AN INTEGRATED YOGA PROGRAM ON QUALITY OF LIFE, SPINAL FLEXIBILITY, AND STRENGTH IN OLDER ADULTS: A RANDOMIZED CONTROL TRIAL. CONTEXT: AGING CAN CONTRIBUTE TO A DECREASE IN PHYSICAL ACTIVITY AS A RESULT OF METABOLIC DYSFUNCTION AND HORMONAL IMBALANCE THAT CAN CAUSE DEGENERATIVE JOINT DISEASE AND AGING-RELATED INFLAMMATION. AS AGE ADVANCES, A DECREASE IN MUSCLE MASS, MUSCLE STRENGTH, AND FLEXIBILITY CAN IMPAIR PHYSICAL FUNCTION. OBJECTIVE: THE STUDY INTENDED TO EVALUATE THE EFFECTS OF AN INTEGRATED YOGA MODULE IN IMPROVING THE FLEXIBILITY, MUSCLE STRENGTH, AND QUALITY OF LIFE (QOL) OF OLDER ADULTS. DESIGN: THIS RESEARCH TEAM DESIGNED A PROSPECTIVE, TWO-ARM, OPEN-LABEL, AND PARALLEL, RANDOMIZED CONTROLLED TRIAL. SETTING: THE STUDY TOOK PLACE IN AN OUTPATIENT DEPARTMENT AT DIVINE PARK, YOGA & NATUROPATHY HOSPITAL, UDUPI, KARNATAKA, INDIA. PARTICIPANTS: PARTICIPANTS WERE 96 OLDER ADULTS, AGED 60-75 YEARS (64.1 +/- 3.95 YEARS) TAKING PART IN A YOGA PROGRAM IN THE DEPARTMENT. INTERVENTION: THE PROGRAM WAS A THREE-MONTH, YOGA-BASED LIFESTYLE INTERVENTION. THE PARTICIPANTS WERE RANDOMLY ALLOCATED TO THE INTERVENTION GROUP (N = 48) OR TO A WAITLISTED CONTROL GROUP (N = 48). THE INTERVENTION GROUP UNDERWENT THREE ONE-HOUR SESSIONS OF YOGA WEEKLY, WITH EACH SESSION INCLUDING LOOSENING EXERCISES, ASANAS, PRANAYAMA, AND MEDITATION SPANNING. OUTCOME MEASURES: AT BASELINE AND POST INTERVENTION, ASSESSMENTS WERE MADE: (1) FOR SPINAL FLEXIBILITY USING A SIT AND REACH TEST, (2) FOR BACK AND LEG STRENGTH USING A BACK LEG DYNAMOMETER, (3) FOR HANDGRIP STRENGTH (HGS) AND ENDURANCE (HGE) USING A HAND-GRIP DYNAMOMETER, AND (4) THE OLDER PEOPLE'S QUALITY OF LIFE (OPQOL) QUESTIONNAIRE. ANALYSIS WAS PERFORMED EMPLOYING WILCOXON'S SIGN RANK TESTS AND MANN WHITNEY TESTS, USING AN INTENTION-TO-TREAT APPROACH. RESULTS: COMPARED TO THE CONTROL GROUP, THE INTERVENTION GROUP EXPERIENCED A SIGNIFICANTLY GREATER INCREASE IN SPINAL FLEXIBILITY (P < .001), BACK LEG STRENGTH (P < .001), HGE (P < .01), AND QOL (P < .001) AFTER THREE MONTHS OF YOGA. CONCLUSION: YOGA CAN BE USED SAFELY FOR OLDER ADULTS TO IMPROVE FLEXIBILITY, STRENGTH, AND FUNCTIONAL QOL. LARGER RANDOMIZED CONTROLLED TRIALS WITH AN ACTIVE CONTROL INTERVENTION ARE WARRANTED. 2022 20 2441 36 YOGA AND SCHIZOPHRENIA-A COMPREHENSIVE ASSESSMENT OF NEUROPLASTICITY: PROTOCOL FOR A SINGLE BLIND RANDOMIZED CONTROLLED STUDY OF YOGA IN SCHIZOPHRENIA. INTRODUCTION: SCHIZOPHRENIA IS ONE OF THE MOST SEVERE MENTAL DISORDERS WITH A PREVALENCE OF ABOUT 1% AND A LEADING CAUSE OF DISABILITY AMONG YOUNG ADULTS. PHARMACOTHERAPY IS THE MAINSTAY IN THE MANAGEMENT OF SCHIZOPHRENIA. HOWEVER, EVEN WITH THE BEST OF MEDICATION, SEVERAL PROBLEMS LIKE REFRACTORINESS, NEGATIVE SYMPTOMS, FREQUENT RELAPSES, AND COGNITIVE IMPAIRMENTS PERSIST. METHODS: THIS IS A RANDOMIZED-CONTROLLED CLINICAL STUDY INCLUDING PATIENTS FROM AN URBAN TERTIARY HOSPITAL AND A SEMI-URBAN COMMUNITY CENTER, WITH A BETWEEN-GROUP, REPEATED-MEASURES, LONGITUDINAL DESIGN. THIS STUDY WILL RECRUIT 160 PATIENTS WITH DSM 5 DIAGNOSIS OF SCHIZOPHRENIA WHO ARE ON STABLE MEDICATION FOR A MINIMUM OF 6 WEEKS; THEY WILL BE RANDOMLY ASSIGNED INTO 2 ARMS VIZ., YOGA THERAPY (YT), AND TREATMENT-AS-USUAL (TAU) WITH 80 PATIENTS IN EACH ARM. PARTICIPANTS WILL UNDERGO CLINICAL, LABORATORY, AND RADIOLOGICAL ASSESSMENTS AT BASELINE AND AT INTERVALS OF 1 MONTH, 3 MONTHS, AND 6 MONTHS FROM THE BASELINE. IT IS HYPOTHESIZED THAT YOGA WILL IMPROVE PSYCHOPATHOLOGY AND EMOTION PROCESSING, INCREASE SERUM BRAIN DERIVED NEUROTROPHIC FACTOR (BDNF) AND PLASMA OXYTOCIN LEVELS AND EFFECT CHANGES IN CEREBRAL ACTIVATION IN AREAS OF THE BRAIN ASSOCIATED WITH SCHIZOPHRENIA. DISCUSSION: THIS STUDY AIMS TO MEASURE THE EFFICACY OF A YOGA-BASED INTERVENTION AS AN ADJUNCT IN PATIENTS WITH SCHIZOPHRENIA AS WELL AS THE MECHANISMS OF THESE EFFECTS. TRIAL REGISTRATION: REGISTERED RETROSPECTIVELY WITH CLINICAL TRIAL REGISTRY - INDIA (CTRI) WITH REGISTRATION NUMBER CTRI/2017/08/009219. 2019